Regenerex Pharma, Inc. has announced that dbbmckennon has resigned as the company's independent registered public accounting firm, effective August 31, 2026. The firm notified the company on August 31, 2026, that it had made an internal decision to cease providing services. dbbmckennon had served in this capacity since 2017.
The company's Board of Directors has acknowledged and accepted the resignation. The reports issued by dbbmckennon for the fiscal years ended December 31, 2025, and March 31, 2025, did not contain an adverse opinion or a disclaimer of opinion. However, both reports included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern. Additionally, the report for the transition period from April 1, 2025, to December 31, 2025, included an explanatory paragraph noting a revision made to the financial statements to disclose certain related party transactions.
The company states that there were no disagreements with dbbmckennon on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure during the two most recent fiscal years. The company is currently in the process of engaging a successor independent registered public accounting firm and intends to complete the engagement process as promptly as practicable.
